Aviance Capital Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.03M | Buy |
41,782
+2,988
| +8% | +$345K | 0.59% | 39 |
|
|
2025
Q4 | $4.08M | Sell |
38,794
-523
| -1% | -$49.1K | 0.47% | 47 |
|
|
2025
Q3 | $3.3M | Buy |
39,317
+1,184
| +3% | +$97.5K | 0.39% | 57 |
|
|
2025
Q2 | $3.02M | Sell |
38,133
-1,562
| -4% | -$124K | 0.39% | 60 |
|
|
2025
Q1 | $3.56M | Sell |
39,695
-25
| -0.1% | -$2.33K | 0.5% | 43 |
|
|
2024
Q4 | $3.95M | Sell |
39,720
-497
| -1% | -$51.2K | 0.55% | 39 |
|
|
2024
Q3 | $4.57M | Buy |
40,217
+68
| +0.2% | +$8.08K | 0.6% | 38 |
|
|
2024
Q2 | $4.97M | Buy |
40,149
+31
| +0.1% | +$3.99K | 0.71% | 31 |
|
|
2024
Q1 | $5.29M | Buy |
40,118
+16,466
| +70% | +$2.03M | 0.79% | 29 |
|
|
2023
Q4 | $2.58M | Sell |
23,652
-1,944
| -8% | -$202K | 0.55% | 39 |
|
|
2023
Q3 | $2.64M | Buy |
25,596
+1,950
| +8% | +$210K | 0.59% | 40 |
|
|
2023
Q2 | $2.73M | Sell |
23,646
-400
| -2% | -$45.4K | 0.58% | 41 |
|
|
2023
Q1 | $2.56M | Buy |
24,046
+2,078
| +9% | +$224K | 0.57% | 40 |
|
|
2022
Q4 | $2.44M | Sell |
21,968
-1,166
| -5% | -$119K | 0.57% | 40 |
|
|
2022
Q3 | $1.99M | Sell |
23,134
-50
| -0.2% | -$4.46K | 0.49% | 51 |
|
|
2022
Q2 | $2.11M | Hold |
23,184
| – | – | 0.47% | 56 |
|
|
2022
Q1 | $1.9M | Sell |
23,184
-503
| -2% | -$39.7K | 0.35% | 79 |
|
|
2021
Q4 | $1.81M | Sell |
23,687
-73
| -0.3% | -$5.81K | 0.3% | 74 |
|
|
2021
Q3 | $1.78M | Buy |
23,760
+311
| +1% | +$23.7K | 0.32% | 78 |
|
|
2021
Q2 | $1.82M | Sell |
23,449
-840
| -3% | -$62.5K | 0.32% | 78 |
|
|
2021
Q1 | $1.79M | Sell |
24,289
-228
| -0.9% | -$16.8K | 0.35% | 71 |
|
|
2020
Q4 | $1.91M | Hold |
24,517
| – | – | 0.39% | 61 |
|
|
2020
Q3 | $1.94M | Hold |
24,517
| – | – | 0.44% | 60 |
|
|
2020
Q2 | $1.81M | Sell |
24,517
-210
| -0.8% | -$15.8K | 0.45% | 56 |
|
|
2020
Q1 | $1.81M | Sell |
24,727
-2,046
| -8% | -$161K | 0.57% | 40 |
|
|
2019
Q4 | $2.32M | Sell |
26,773
-832
| -3% | -$68.3K | 0.59% | 46 |
|
|
2019
Q3 | $2.22M | Sell |
27,605
-5,423
| -16% | -$435K | 0.65% | 38 |
|
|
2019
Q2 | $2.64M | Buy |
33,028
+409
| +1% | +$31.3K | 0.73% | 26 |
|
|
2019
Q1 | $2.59M | Sell |
32,619
-270
| -0.8% | -$20.2K | 0.74% | 23 |
|
|
2018
Q4 | $2.4M | Sell |
32,889
-781
| -2% | -$55.1K | 0.84% | 23 |
|
|
2018
Q3 | $2.28M | Buy |
33,670
+1,205
| +4% | +$76.8K | 0.55% | 36 |
|
|
2018
Q2 | $1.88M | Buy |
32,465
+16,154
| +99% | +$911K | 0.54% | 46 |
|
|
2018
Q1 | $847K | Hold |
16,311
| – | – | 0.26% | 118 |
|
|
2017
Q4 | $876K | Hold |
16,311
| – | – | 0.29% | 104 |
|
|
2017
Q3 | $997K | Hold |
16,311
| – | – | 0.34% | 85 |
|
|
2017
Q2 | $998K | Sell |
16,311
-48
| -0.3% | -$2.92K | 0.32% | 90 |
|
|
2017
Q1 | $992K | Sell |
16,359
-54
| -0.3% | -$3.28K | 0.36% | 84 |
|
|
2016
Q4 | $922K | Buy |
16,413
+153
| +0.9% | +$8.95K | 0.33% | 87 |
|
|
2016
Q3 | $968K | Buy |
16,260
+99
| +0.6% | +$5.79K | 0.34% | 79 |
|
|
2016
Q2 | $888K | Sell |
16,161
-177
| -1% | -$9.42K | 0.33% | 87 |
|
|
2016
Q1 | $825K | Sell |
16,338
-324
| -2% | -$15.9K | 0.29% | 96 |
|
|
2015
Q4 | $840K | Buy |
16,662
+340
| +2% | +$17.1K | 0.29% | 102 |
|
|
2015
Q3 | $769K | Buy |
16,322
+70
| +0.4% | +$3.72K | 0.32% | 101 |
|
|
2015
Q2 | $883K | Sell |
16,252
-721
| -4% | -$40.4K | 0.33% | 94 |
|
|
2015
Q1 | $931K | Buy |
16,973
+614
| +4% | +$34.8K | 0.34% | 83 |
|
|
2014
Q4 | $886K | Sell |
16,359
-313
| -2% | -$17.4K | 0.33% | 87 |
|
|
2014
Q3 | $943K | Sell |
16,672
-2,010
| -11% | -$113K | 0.36% | 75 |
|
|
2014
Q2 | $1.03M | Buy |
18,682
+2
| +0% | +$109 | 0.4% | 72 |
|
|
2014
Q1 | $1.01M | Sell |
18,680
-2,093
| -10% | -$108K | 0.43% | 61 |
|
|
2013
Q4 | $992K | Sell |
20,773
-9,313
| -31% | -$426K | 0.42% | 60 |
|
|
2013
Q3 | $1.37M | Buy |
30,086
+1,488
| +5% | +$67.9K | 0.64% | 39 |
|
|
2013
Q2 | $1.27M | Buy |
+28,598
| New | +$1.28M | 0.68% | 43 |
|
Other funds holding MRK
VCM
VPM
Aviance Capital Partners's MRK Position: Q1 2026 in Review
Aviance Capital Partners increased its Merck (MRK) stake by 7.7% in Q1 2026, buying an estimated $345K and bringing the position to 41,782 shares worth $5.03M. The position accounts for 0.59% of the portfolio, ranked #39.
Aviance Capital Partners first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.29M in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Aviance Capital Partners held 41,782 shares of Merck worth $5.03M as of Q1 2026.
- Aviance Capital Partners bought 2,988 Merck shares in Q1 2026, an estimated $345K.
- Merck made up 0.59% of Aviance Capital Partners's portfolio in Q1 2026, its #39 holding.
- Aviance Capital Partners first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- Aviance Capital Partners's Merck position peaked at $5.29M in Q1 2024.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Aviance Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.